CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 370819-371113 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2824","span":{"begin":0,"end":294},"obj":"Sentence"},{"id":"T23389","span":{"begin":0,"end":294},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The emergence of multi-drug-resistant pathogens, including methicillinresistant Staphylococcus aureus (MRSA), combined with the absence of new antibiotics from the pharmaceutical sector demands that alternative anti-MRSA agents are scientifically evaluated and developed as a matter of urgency."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T221","span":{"begin":0,"end":294},"obj":"Sentence"}],"text":"The emergence of multi-drug-resistant pathogens, including methicillinresistant Staphylococcus aureus (MRSA), combined with the absence of new antibiotics from the pharmaceutical sector demands that alternative anti-MRSA agents are scientifically evaluated and developed as a matter of urgency."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1232","span":{"begin":103,"end":107},"obj":"Disease"},{"id":"T1233","span":{"begin":216,"end":220},"obj":"Disease"},{"id":"T97449","span":{"begin":103,"end":107},"obj":"Disease"},{"id":"T5265","span":{"begin":216,"end":220},"obj":"Disease"}],"attributes":[{"id":"A1232","pred":"mondo_id","subj":"T1232","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A1233","pred":"mondo_id","subj":"T1233","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A56890","pred":"mondo_id","subj":"T97449","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A55836","pred":"mondo_id","subj":"T5265","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"The emergence of multi-drug-resistant pathogens, including methicillinresistant Staphylococcus aureus (MRSA), combined with the absence of new antibiotics from the pharmaceutical sector demands that alternative anti-MRSA agents are scientifically evaluated and developed as a matter of urgency."}